Literature DB >> 2029098

Transfusion-associated graft-versus-host disease in an immunocompetent patient.

S M Capon1, W D DePond, D B Tyan, S H Pepkowitz, H Toyoda, A C Cinman, P C Azer, D Goldfinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2029098     DOI： 10.7326/0003-4819-114-12-1025

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease.

Authors:  D F Friedman; P Kwittken; B Cizman; E Argyris; J Kearns; S Y Yang; C Zmijewski; N Bunin; S D Douglas; D Monos
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

2.  Transfusion associated graft versus host disease in an immunocompetent patient.

Authors:  N T O'Connor; P Mackintosh
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.